About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Study on Complete Response Rates of Chemotherapy for Late-Stage Cancer

by Dr. Trupti Shirole on November 28, 2015 at 7:49 PM
Font : A-A+

 New Study on Complete Response Rates of Chemotherapy for Late-Stage Cancer

Chemotherapy refers to cancer treatment that uses chemical substances, especially one or more anti-cancer drugs, to kill the cancer cells in the body. A meta-analysis of 68 chemotherapy trials for cancer treatment between 2000 and 2006 has suggested that regardless of cancer types, chemotherapeutic agent or dose regimen used, the complete response (CR) rates for patients were equally low, between 5-10% across most cancer types, with a mean of 7.41%.

The researchers noted that such low values and such a high similarity in response rates between cancer types and treatments is both unusual and surprising.

Advertisement


There are, however, rare notable exceptions, such as testicular carcinoma and childhood acute lymphoblastic leukemia, which are known to be highly chemo-responsive with CR rates of around 80-90%; these were not covered by this research.

Brendon Coventry, the Principal Investigator for the study, said, "The finding that late stage cancer CR rates have remained at a similarly low level over this six-year period, despite diligent clinical effort to improve therapies, strongly suggests that an underlying mechanism is preventing rates from increasing above 10%. If this mechanism can be further understood or overcome, CR rates could be significantly increased."
Advertisement

Although this research looked at trials conducted between 2000 and 2006, it is still highly relevant today because, as Coventry said, "CR rates even from 'targeted' therapies are often around 5-10% too, indicative of some underlying mechanism limiting the ability to produce CRs in patients."

Although 'targeted' cancer therapies are becoming more widely used, they only work in a subset of patients with the 'right' type of mutation in their tumors. As such, many patients without those mutations still only receive chemotherapy regimens. It remains to be seen how targeted therapies can improve on CR rates in advanced cancer patients.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Cancer Facts Cancer Tattoos A Body Art Peritoneal Cancer 

Most Popular on Medindia

A-Z Drug Brands in India Blood Pressure Calculator Drug Side Effects Calculator Drug - Food Interactions Accident and Trauma Care Noscaphene (Noscapine) Sinopril (2mg) (Lacidipine) Calculate Ideal Weight for Infants Loram (2 mg) (Lorazepam) Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Study on Complete Response Rates of Chemotherapy for Late-Stage Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests